Data / Form D filings / OLFAX, LLC
OLFAX, LLC: Form D filing
OLFAX, LLC, a pharmaceuticals company in Asheville, NC, filed a Form D with the SEC in 2024. The latest, on June 11, 2024, reports $110,000 sold of a $600,000 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16 BILTMORE AVE, STE 300, Asheville, NC, 28801
- Phone
- (603) 667-3484
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- North Carolina
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2026135
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | New notice | $600,000 | $110,000 | $490,000 | 3 | May 30, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jason T Cook | Executive Officer | |
| Wesley J Cook | Executive Officer | |
| Jonathan Beckwith | Executive Officer |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Jun 10, 2024 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what OLFAX, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.